The application of enhanced parallel gatekeeping strategies

被引:38
作者
Chen, X [1 ]
Luo, XH [1 ]
Capizzi, T [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
closed testing; interrelationship; matching; minimum primary weight; strong control;
D O I
10.1002/sim.2005
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The parallel gatekeeping strategy proposed by Dmitrienko et al. (Statist. Med. 2003; 22:2387-2400) provides a flexible framework for the pursuit of strong control on Study wise type I error rate. This paper further explores the application of the weighted Simes parallel gatekeeping procedure recommended by Dmitrienko et al. and proposes some modifications to it to better incorporate the interrelationships of different hypotheses in actual clinical trials and to achieve better power performance. We first propose a simple method to quantitatively control the impact of secondary tests on the testing of primary hypotheses. We then introduce a matched gatekeeping procedure to exemplify how to address special relationships between individual primary and secondary tests following the parallel gatekeeping framework. Our simulation stud), demonstrates that the enhanced gatekeeping procedures generally result in more powerful tests than the parallel gatekeeping procedure in Dmitrienko et al. whenever applicable. Copyright (c) 2004 John Wiley & Sons, Ltd.
引用
收藏
页码:1385 / 1397
页数:13
相关论文
共 10 条
[1]  
Benjamini Y, 2001, ANN STAT, V29, P1165
[2]   Multiple hypotheses testing with weights [J].
Benjamini, Y ;
Hochberg, Y .
SCANDINAVIAN JOURNAL OF STATISTICS, 1997, 24 (03) :407-418
[3]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[4]   Gatekeeping strategies for clinical trials that do not require all primary effects to be significant [J].
Dmitrienko, A ;
Offen, WW ;
Westfall, PH .
STATISTICS IN MEDICINE, 2003, 22 (15) :2387-2400
[5]   Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial [J].
Hartung, HP ;
Gonsette, R ;
König, N ;
Kwiecinski, H ;
Guseo, A ;
Morrissey, SP ;
Krapf, H ;
Zwingers, T .
LANCET, 2002, 360 (9350) :2018-2025
[6]  
Hochberg Y, 2000, HANDB STAT, V18, P75, DOI 10.1016/S0169-7161(00)18006-X
[7]   CLOSED TESTING PROCEDURES WITH SPECIAL REFERENCE TO ORDERED ANALYSIS OF VARIANCE [J].
MARCUS, R ;
PERITZ, E ;
GABRIEL, KR .
BIOMETRIKA, 1976, 63 (03) :655-660
[8]   Practical guidelines for multiplicity adjustment in clinical trials [J].
Proschan, MA ;
Waclawiw, MA .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :527-539
[9]  
QUAN H, 2003, 094 BARDS MERCK RES
[10]   PROBLEMS OF MULTIPLICITY IN CLINICAL-TRIALS [J].
SIMON, R .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1994, 42 (1-2) :209-221